# A Multicenter Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Subjects

> **NCT00249860** · PHASE3 · COMPLETED · sponsor: **EMD Serono** · enrollment: 257 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** Interferon-beta-1a
- **DRUG:** Placebo
- **DRUG:** Ribavirin plus Interferon-beta-1a

## Key facts

- **NCT ID:** NCT00249860
- **Lead sponsor:** EMD Serono
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2005-08
- **Final completion:** 2005-08
- **Target enrollment:** 257 (ACTUAL)
- **Last updated:** 2013-08-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00249860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00249860, "A Multicenter Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian Subjects". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00249860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*